Delivery Order SPE2DB22D2211-SPE2DB25FSBVE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,103.84 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on October 28, 2025, with completion scheduled for October 29, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency has awarded a delivery order valued at $1,730.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16-gram units. This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order was awarded on September 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,073.79 for Fluticasone Propionate 50 MCG Spray in 16GM units, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract was awarded on a firm fixed price basis without any set-aside designation, indicating competitive award through open competition. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.61 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a direct fulfillment order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,158.11 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 gm) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's extensive supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,165.50 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate 50 MCG Spray (16 grams). This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and was awarded on July 30, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.08 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray in 16-gram units under a firm fixed-price contract. The award, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance location for this delivery order, which falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16 GM units. This non-competitive award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed-price delivery order under a larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBVEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,756.80 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 29, 2025, with completion due by July 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, supplies an extensive range of medical products including brand-name and generic medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capacity to fulfill diverse pharmaceutical requirements through open competition underscores its critical role in supporting federal military and veteran healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/29/25 |